Large-scale labeling and assessment of sex bias in publicly available expression data

Background: Women are at more than 1.5-fold higher risk for clinically relevant adverse drug events. While this higher prevalence is partially due to gender-related effects, biological sex differences likely also impact drug response. Publicly available gene expression databases provide a unique opp...

Full description

Bibliographic Details
Main Authors: Altman, R.B (Author), Chang, A. (Author), Flynn, E. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2021
Subjects:
Online Access:View Fulltext in Publisher